SINDROME METABOLICA
CARATTERISTICHE
AMINO PHARBES
100 compresse da 1,2 g

AminoPharbes è un sostituto sano ed efficace delle proteine alimentari costituito da una composizione esclusiva di aminoacidi essenziali in forma cristallina, libera, altamente purificata che vengono assimilati rapidamente (in 30 minuti).

APPROFONDIMENTI
SCHEDA INGREDIENTI
BIBLIOGRAFIA SCIENTIFICA

BIBLIOGRAFIA  Amino Pharbes

  • Brooks GA. Anaerobic threshold: review of the concept and direction for future research. Med Sci Sports Exercise. 1985;17:22-31.

  • Bufalini L. Rieducazione nutrizionale e terapia omotossicologica in pazienti anoressiche amenorroiche. La Medicina Biologica; 3: 67-71, 2001.

  • Burke L.M., Kiens B., Ivy J.L. – Carbohydrates and fat for training and recovery. J Sports Sci. 2004 Jan;22(1):15-30.

  • Cairella; Jacobelli Obesità: un problema. Si può risolvere? Capelli Editore 1983.

  • Campbell B., Kreider R.B., Ziegenfuss T., La Bounty P., Roberts M., Burke D., Landis J., Lopez H., Antonio J. – International Society of Sports Nutrition position stand: protein and exercise. J Int Soc Sports Nutr. 2007 Sep 26;4:8.

  • Chandra RK, Gupta S, Singh H. Inducer and suppressor T-cell subsets in protein-energy malnutrition: analysis by monoclonal antibodies. Nutr Res. 1982;2:21-26.

  • Chandra RK.Nutrition, immunity, and infection: present knowledge and future directions. Lancet. 1983;1:688-691.

  • Clark RG Growth hormone secretagogues stimulate the hypothalamic-pituitary-adrenal axis and are diabetogenic in the Zucker diatebetic fatty rat. Endocrinology 138 (10), 4316-4323 (1997)

  • Corgna M. Pnei e patologie psiconutrizionali in omotossicologia. Il trattamento delle sindromi bulimiche. La Medicina Biologica; 3: 8-16, 2000.

  • Creff, Herschberg Obesità. Masson ed. 1981.

  • Davies GJ. A Compendium of Isokinetics in Clinical Usage. 2nd ed. La Crosse, Wis: S and S Publishers; 1985. Advances In Therapy” Volume 20 No.4, July/August 2003 209.

  • De Cristofano C., Giordano F. Terapia omeopatica integrata in un caso di cirrosi epatica scompensata. La Medicina Biologica; 51-52, 2002.

  • Del Prete M. Le malattie infiammatorie intestinali: importanza diagnostica e terapeutica del MAP. La Medicina Biologica 3: 20-26, 2001.

  • Di Tullio G. La Malattia asmatica: il ruolo della nutrizione biologica. La Medicina Biologica; 3: 15-19, 2001.

  • F. Branca, H. Nikogosian, T. Lobstein – “The challenge of obesity in the Who European Region and the strategies for response: summary” – Denmark, 2007.

  • Gibala M.J. – Protein metabolism and endurance exercise. Sports Med. 2007;37(4-5):337-40.

  • Hawley J.A., Spargo F.J. – Metabolic adaptations to marathon training and racing. Sports Med. 2007;37(4-5):328-31.

  • Hawley J.A., Tipton K.D., Millard-Stafford M.L. – Promoting training adaptations through nutritional interventions. J Sports Sci. 2006 Jul;24(7):709-21.

  • Hermann G.F. Le intolleranze alimentari. La Medicina Biologica; 3: 3-7, 2000.

  • http://www.biomedcentral.com/1472-6963/8/75

  • http://www.sicob.org/

  • Ivaldi G.P. Esperienza nutrizionale in pazienti con insufficienza respiratoria. La Medicina Biologica; 3:49-54, 2000.

  • Keller, Kathleen, Encyclopedia of Obesity, Thousand Oaks, Calif, Sage Publications, Inc, 2008. ISBN 1-4129-5238-7

  • L. Arsenio, A. Strata Alimentazione ed esercizio fisico – 1995 – Guatteri S.p.A. Praticello di Galtatico (R.E.).

  • Levy-Navarro, Elena, The Culture of Obesity in Early and Late Modernity (in inglese), Palgrave Macmillan, 2008. ISBN 0230601235

  • Loucks A.B. – Low energy availability in the marathon and other endurance sports. Sports Med. 2007;37(4-5):348-52.

  • Luca-Moretti M, Grandi A, Luca E, et aL Comparative results between two groups of track-andfield athletes with or without the use of Master Amino acid Pattern@ as protein substitute. Adv Ther. 2003;20:195-202.

  • Luca-Moretti M, Grandi A, Luca E, et aL Master Amino acid Pattern@ as substitute for dietary proteins during a weight-loss diet to achieve the body’s nitrogen balance equilibrium with essentially no calories. Adv Ther.2003;20:282-291.

  • Luca-Moretti M, Grandi A, Luca E, et aL Results of taking Master Amino acid Pattern@ as a sole and total substitute of dietary proteins in an athlete during a desert crossing. Adv Ther. 2003;20: 203-210.

  • Luca-Moretti M, Grandi A, Luca E, et al. Comparative results between two groups of track-andfieldathletes with or without the use of Master Amino acid Pattern@as a protein substitute. Adv Ther. 2003;20:195-202.

  • Luca-Moretti M, Grandi A. The malnutrition treatment and prevention project. JIMHA. 1993; 2:21-27.
  • Luca-Moretti M. The discovery of the Master Amino acid Pattern. Ann R AcadMed Spain. 1998; 2:397-416.
  • Luca-Moretti M. The International Nutrition Research Center overweight management program. The US Library of Congress, 1999.

  • Lucà-Moretti, M., Grandi A., Lucà E., Mariani E., Vender G., Arrigotti E., Ferrario M., Rovelli E Results of taking Master Amino Acids Pattern® as a sole and total substitute of dietary proteins in an athlete during a desert crossing. Advances in Theraphy; 4:203-210, 2003.

  • Lucà-Moretti, M., Grandi A., Lucà E., Mariani E., Vender G., Arrigotti E., Ferrario M., Rovelli E. Comparative Results Between Two Groups of Track and Field Athletes with or without the use of Master Amino Acids Pattern® as protein substitute. Advances in Theraphy; 4:195-202, 2003.

  • Lucà-Moretti, M., Grandi A., Lucà E., Muratori G., Nofroni M.G., Mucci M.P., Gambetta P., Stimolo R., Drago P., Giudice G., Tamburlin N. Master Amino Acids Pattern® as substitute for dietary proteins during a weight loss diet to achieve the body’s Nitrogen Balance equilibrium with essentially no calories. Advances in Therapy; 5:282-291, 2003.

  • Lucà-Moretti, M., Grandi A., Lucà E., Muratori G., Nofroni M.G., Mucci M.P., Gambetta P., Stimolo R., Drago P., Giudice G., Tamburlin N., Karbalay M., Valente C., Moras G. Master Amino Acids Pattern® as sole and total substitute for dietary proteins during a weight loss diet to achieve the body’s Nitrogen Balance equilibrium. Advances in Theraphy; 5:270-281, 2003.

  • M. Ceccarelli M.D et al. Trattamento dietetico delle adiposità localizzate International Centre for Study And Research in Aestetic and Physiological Medicine – Roma 2009

  • Mariani M.M. Utilizzo del MAP (Master Amino acid Pattern) nel Programma “Quattro D” nell’insufficienza venosa cronica. La Medicina Biologica 3: 33-40, 2001.

  • Marucci S. Linfedema ereditario e malassorbimento proteico con deficit secondario di HGH. La Medicina Biologica; 21-25, 2004.

  • Nutrition for Athletics, a practical guide to eating and drinking for health and performance in track and field. Based on an IAAF conference held in Monaco in April 2007.

  • Paul Poirier, Thomas D. Giles, George A. Bray, Yuling Hong, Judith S. Stern, F. Xavier Pi-Sunyer, Robert H. Eckel. Obesity and cardiovascular disease: pathophysiology, evaluation, and effect of weight loss. Circulation. 2006;113:898-918.

  • Penco P., Frigerio F., Orlandi S., Molinari R. Progetto SET/K13: Rilievi su un caso estremo. La Medicina Biologica; 15-22, 2006.

  • Rodriguez N.R., Di Marco N.M., Langley S. – American Dietetic Association; Dietitians of Canada; American College of Sports Medicine. Position of the American Dietetic Association, Dietitians of Canada, and the American College of Sports Medicine: Nutrition and athletic performance. J Am Diet Assoc. 2009 Mar;109(3):509-27.

  • Sartorio A., Silvestri G. Obesità: per saperne di più. Edizioni Edra, 2002.

  • Schröder S., Fischer A., Vock C., Böhme M., Schmelzer C., Döpner M., Hülsmann O., Döring F. – Nutrition concepts for elite distance runners based on macronutrient and energy expenditure. J Athl Train. 2008 Sep-Oct;43(5):489-504.

  • Shirreffs S.M., Casa D.J., Carter R. – 3rd International Association of Athletics Federations. Fluid needs for training and competition in athletics. J Sports Sci. 2007;25 Suppl 1:S83-91.

  • Smythe PM, Brereton-Stiles GG, Grace HI, et al. Thymolymphatic deficiency and depression of cell-mediated immunity in protein-calorie malnutrition. Lancet. 1971;2:939-943.

  • Spriet L.L. – Regulation of substrate use during the marathon. Sports Med. 2007;37(4-5):332-6.

  • Stellingwerff T., Boit M.K., Res P.T. – International Association of Athletics Federations. Nutritional strategies to optimize training and racing in middle-distance athletes. J Sports Sci. 2007;25 Suppl 1:S17-28.

  • Tamburlin N. Correlazioni tra micosi cutanee ed intolleranze alimentari. La Medicina Biologica; 67-75, 2001.

  • Tamburlin N. Trattamento ambulatoriale di pazienti con insufficienza renale cronica, La Medicina Biologica; 3: 12-16, 1999.

  • Tanaka K, Matsuura Y. Marathon performance, anaerobic threshold, and onset of blood lactate

  • Turco L. Rete ippocampale come modello della late-life: approccio farmacologico di regolazione nel senex. La Medicina Biologica; 55-59, 2004.

  • Vender G, Rovelli E. Valori di riferimento dei principali parametri di massima potenza anaerobica misurati tramite ergometro isocinetico Cybex 340. Med Sport. 1994;47: 775-781.

  • Vender G, Rovelli E. Variazione delle prestazioni di massima potenza anaerobica in funzione dell’eta. Med Sport. 1994;47:783-786.

Related Projects